SIOX Sio Gene Therapies

Sio Gene Therapies Inc.
Companies
1993+
Filing Dates

380 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
4
Pande Atul
26 Nov 20
Sio Gene Therapies / Atul Pande ownership change
EFFECT
SIOX Sio Gene Therapies Inc.
20 Nov 20
Notice of effectiveness
EFFECT
SIOX Sio Gene Therapies Inc.
20 Nov 20
Notice of effectiveness
S-8 POS
SIOX Sio Gene Therapies Inc.
13 Nov 20
Registration of securities for employees (post-effective amendment)
POS AM
SIOX Sio Gene Therapies Inc.
13 Nov 20
Prospectus update (post-effective amendment)
POS AM
SIOX Sio Gene Therapies Inc.
13 Nov 20
Prospectus update (post-effective amendment)
8-K
SIOX Sio Gene Therapies Inc.
13 Nov 20
Results of Operations and Financial Condition
10-Q
2021 Q2
SIOX Sio Gene Therapies Inc.
13 Nov 20
Quarterly report
EFFECT
SIOX Sio Gene Therapies Inc.
13 Nov 20
Notice of effectiveness
S-4/A
SIOX Sio Gene Therapies Inc.
10 Nov 20
Registration of securities issued in business combination transactions (amended)
8-K
SIOX Sio Gene Therapies Inc.
10 Nov 20
Axovant Gene Therapies Announces Name Change to Sio Gene Therapies
8-K
SIOX Sio Gene Therapies Inc.
9 Nov 20
Axovant Gene Therapies Announces FDA Clearance of IND for AXO-AAV-GM2 Gene Therapy in Tay-Sachs and Sandhoff Diseases
8-K
SIOX Sio Gene Therapies Inc.
29 Oct 20
Regulation FD Disclosure
8-K
SIOX Sio Gene Therapies Inc.
13 Oct 20
Axovant Gene Therapies Receives Rare Pediatric Disease Designation for AXO-AAV-GM2 for Tay-Sachs and Sandhoff Disease
8-K
SIOX Sio Gene Therapies Inc.
9 Oct 20
Axovant Gene Therapies Receives Rare Pediatric Disease Designation for AXO-AAV-GM1 for GM1 Gangliosidosis
8-K
SIOX Sio Gene Therapies Inc.
8 Oct 20
Departure of Directors or Certain Officers
4
SIOX Sio Gene Therapies Inc.
8 Oct 20
Axovant Gene Therapies / Kristiina MD Vuori ownership change
3
SIOX Sio Gene Therapies Inc.
8 Oct 20
Axovant Gene Therapies / Kristiina MD Vuori ownership change
8-K
SIOX Sio Gene Therapies Inc.
6 Oct 20
Axovant Gene Therapies Announces Positive Six-month Follow-up Data from Second
8-K
SIOX Sio Gene Therapies Inc.
2 Oct 20
Other Events